Investigation of cis/trans ratios of peptide bonds in AVP analogues containing N-methylphenylalanine enantiomers

Journal of Peptide Science

Volumn 12, Issue 1, 2006, Pages 13-24

  Sikorska, Emilia ^a   Ślusarz, Magdalena J ^a   Ślusarz, Rafał ^a   Kowalczyk, Wioleta ^a   Lammek, Bernard ^a  

^a UNIVERSITY OF GDA SK   (Poland)

Author keywords

EDMC; N methylation; NMR spectroscopy; Peptide conformation; Vasopressin

Indexed keywords

DEUTERIUM OXIDE; NEUROHYPOPHYSIS HORMONE; UNCLASSIFIED DRUG; VASOPRESSIN DERIVATIVE; VASOPRESSIN[2 METHYLPHENYLALANINE 3 DEXTRO METHYLPHENYLALANINE]; VASOPRESSIN[DEXTRO CYSTEINE 2 METHYLPHENYLALANINE 3 DEXTRO METHYLPHENYLALANINE];

ARTICLE; CIS TRANS ISOMERISM; CONFORMATIONAL TRANSITION; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN MODIFICATION; PROTEIN SYNTHESIS; RACEMIZATION; SPECTROSCOPY; STRUCTURE ACTIVITY RELATION;

ANIMALS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDES; PHENYLALANINE; REFERENCE STANDARDS; STEREOISOMERISM; VASOPRESSINS;

EID: 29844451699     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.684     Document Type: Article

References (60)

1. Toniolo C. Conformationally restricted peptides through short-range cyclization. Int. J. Pept. Protein Res. 1990; 35: 287-300.
2. Yamashita T, Takenaka, H, Kojima Y. Preparations of N,N′-ethylene-bridged dipeptides (eXX) constructed from (S)-methionine, -tryptophan, -tyrosine, -N(ε)-benzyloxycarbonyllysine through acid catalyzed cyclization. Amino Acids 1993; 4: 187-192.
3. Dyson HJ, Rance M, Hoighten RA, Lerner RA, Wright PE. Folding of immunogenic peptide fragments of proteins in water solution. I. Sequence requirements for the formation of a reverse turn. J. Mol. Biol. 1988; 201: 161-200.
4. 3 peptide bond of arginine vasopressin analogs. J. Pept. Res. 2004; 63: 333-346.
5. Vitoux B, Aubry A, Cung MT, Marrad M. N-Methyl peptides. VII. Conformational perturbations induced by N-methylation of model dipeptides. J. Pept. Protein Res. 1986: 27: 617-632.
6. Hruby VJ, Upson DA, Yamamoto DM, Smith CW, Walter R. Active site studies of neurohypophyseal hormones. Comparison of oxytocin and arginine vasopressin analogs containing 2-D-tyrosine J. Am. Chem. Soc. 1979; 101: 2717-2721.
7. Kowalczyk W, Derdowska I, Dawidowska O, Prahl A. Hartrodt B, Neubert K, Slaninova J, Lammek B. Analogues of arginine vasopressin modified in the N-terminal part of the molecule with enantiomers of N-methylphenylalanine. J. Pept. Res. 2004; 63: 420-425.
8. Bax A, Freeman R. Enhanced NMR resolution by restricting the effective sample volume. J. Magn. Reson. 1985; 65: 355-360.
9. Braunschweiler L, Ernst RR. Coherence transfer by isotropic mixing: Application to correlation spectroscopy. J. Magn. Reson. 1983; 53: 521-528.
10. Bax A, Davis DG. Practical aspects of two-dimensional transverse NOE spectroscopy. J. Magn. Reson. 1985; 63: 207-213.
11. Palmer III AG, Cavanagh J, Wright PE, Rance M. Sensitivity improvement in proton-detected two dimensional heteronuclear correlation NMR spectroscopy. J. Magn. Reson. 1991; 93: 151-170.
12. Kay LE, Keifer P, Saarinen T. Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity. J. Am. Chem. Soc. 1992; 114: 10663-10665.
13. Kontaxis G, Stonehouse J, Laue ED, Keeler J. The sensitivity of experiments which use gradient pulses for coherence-pathway selection. J. Magn. Reson. Ser. A 1994; 111: 70-76.
14. 13C Assignments from sensitivity-enhanced detection of heteronuclear multiple-bond connectivity by 2D multiple quantum NMR. J. Am. Chem. Soc. 1986; 108: 2093-2094.
15. Delaglio F, Grzesiek S, Geerten WV, Zhu G, Pfeifer J, Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 1995; 6: 277-293.
16. Bartles C, Xia T, Billeter M, Günter P, Wüthrich K. The program XEASY for the computer-supported NMR spectral analysis of biological macromolecules. J. Biomol. NMR 1995; 5: 1-10.
17. Gottlieb HE, Kotlyar V, Nudelman A. NMR Chemical shifts of common laboratory solvents as trace impurities. J. Org. Chem. 1997; 62: 7512-7515.
18. Wishart DS, Bigam CG, Holm A, Hodges RS, Sykes BD. 1H, 13C and 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects. J. Biomol. NMR 1995; 5: 67-81.
19. Koźminski W. The new active-coupling-pattern tilting experiment for an efficient and accurate determination of homonuclear coupling constants. J. Magn. Reson. 1998; 134: 189-193.
20. Dorman DE, Bovey FA. Carbon magnetic resonance spectroscopy. The spectrum of proline in oligopeptides. J. Org. Chem. 1973; 38: 2379-2383.
21. Schmidt JM, Ohlenschläger O, Rüterjans H, Grzonka Z, Kojro E, Pavo I, Fahrenholz F. Conformation of [8-arginine]vasopressin and V1 antagonists in dimethyl sulfoxide solution derived from two-dimensional NMR spectroscopy and molecular dynamics simulation. Eur. J. Biochem. 1991; 201: 355-371.
22. Ripoll DR, Scheraga HA. On the multiple-minima problem in the conformational analysis of polypeptides. II. An electronically driven Monte Carlo method - tests on poly(L-alanine). Biopolymers 1988; 27: 1283-1303.
23. Némethy G, Gibson KD, Palmer KA, Yoon CN, Paterlini G, Zagari A, Rumsey S, Scheraga HA. Energy parameters in polypeptides. 10. Improved geometrical parameters and nonbonded interactions for use in the ECEPP/3 algorithm with application to proline-containing peptides. J. Phys. Chem. 1992; 96: 6472-6484.
24. Vila J, Williams RL, Vsasquez M, Scheraga HA. Empirical solvation models can be used to differentiate native from near-native conformations of bovine pancreatic trypsin inhibitor. Proteins Struct. Funct. Genet. 1991; 10: 199-218.
25. Späth H. Cluster analysis algorithms. J. Comput. Chem. 1980; 10: 209-220.
26. Meadows RP, Post CB, Luxon BA, Gorenstein DG. MORASS 2.1. Purdue University: West Lafayette, 1994.
27. Post CB, Meadows RP, Gorenstein DG. On the evaluation of interproton distance for 3-dimensional structure determination by NMR using a relaxation rate matrix analysis. J. Am. Chem. Soc. 1990; 112: 6796-6803.
28. Massefski W Jr, Bolton PH. Quantitative analysis of nuclear Overhauser effects. J. Magn. Reson. 1985; 65: 526-530.
29. Bystrov VF. Spin-spin coupling and the conformational states of peptide systems. Progr. NMR Spectrosc. 1976; 10: 41-81.
30. Yu C, Yang TH, Yeh CJ, Chuang LC. Combined use of NMR, distance geometry, and restrained energy minimization for the conformational analysis of 8-lysinevasopressin. Can. J. Chem. 1992; 70: 1950-1955.
31. Marquard DW. An algorithm for least squares estimation of nonlinear parameters. J. Soc. Industr. Appl. Math. 1963; 11: 431-441.
32. Lewis PN, Mamony FA, Scheraga HA. Chain reversals in proteins. Biochem. Biophys. Acta 1973; 303: 211-229.
33. McDonald IK, Thornton JM. Satisfying hydrogen bonding potential in proteins. J. Mol. Biol. 1994; 238: 777-793.
34. Koradi R, Billeter M, Wüthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graphics 1996; 14: 52-55.
35. Hagler AT, Osguthorpe DJ, Dauber-Osguthorpe P, Hempel JC. Dynamics and conformational energetics of a peptide hormone: vasopressin. Science 1985; 227: 1309-1315.
36. Deslauriers R, Smith ICP. Evidence from proton magnetic resonance data for the stacking of amino acids in lysine-vasopressin: comparison with oxytocin derivatives and related dipeptides. Biochem. Biophys. Res. Commun. 1976; 40: 179-185.
37. Walter P. Identification of sites in oxytocin involved in uterine receptor recognition and activition. Fed. Proc. 1977; 36: 1872-1878.
38. Breslow E. Chemistry and biology of the neurophysin. Annu. Rev. Biochem. 1979; 48: 251-274.
39. Walter R, Schwartz IL, Darnell JH, Urry DW. Relation of the conformation of oxytocin to the biology of neurohypophyseal hormones. Proc. Natl Acad. Sci. USA 1971; 68: 1355-1359.
40. Hruby VJ. Structure and conformation related to the activity of peptide hormones. In Perspectives in Peptide Chemistry, Eberle A, Geiger R, Wieland T (eds). Karger: Basel, Switzerland, 1981; 207-220.
41. Hruby VJ. Implications of the x-ray structure of deamino-oxytocin to agonist/antagonist-receptor interactions. Trends Pharmacol. Sci. 1987; 8: 336-339.
42. Hruby VJ, Deb KK, Fox J, Bjarnason J, Tu AT. Conformational studies of peptide hormones using laser Raman and circular dichroism spectroscopy. J. Biol. Chem. 1978; 253: 6060-6067.
43. Wang J, Hodges RS, Sykes BD. Effect of trifluoroethanol on the solution structure and flexibility of desmopressin: a two-dimensional NMR study. J. Am. Chem. Soc. 1995; 117: 8627-8634.
44. Walse B, Kihlberg J, Drakenberg T. Conformation of desmopressin, an analogue of the peptide hormone vasopressin, in aqueous solution as determined by NMR spectroscopy. Eur. J. Biochem. 1998; 252: 428-440.
45. Walter R, Ballardin A, Schwartz IL, Gibbons WA, Wyssbrod HR. Conformational studies on arginine vasopressin and arginine vasotocin by proton magnetic resonance spectroscopy. Proc. Natl Acad. Sci. USA 1974; 71: 4528-4532.
46. 8] vasopressin by 1H-NMR spectroscopy and molecular mechanics calculations. Int. J. Pept. Protein Res. 1991; 38: 528-538.
47. Shenderovich MD, Kover KE, Wilke S, Collins N, Hruby VJ. Solution conformations of potent bicycle antagonists of oxytocin by nuclear magnetic resonance spectroscopy and molecular dynamics simulations. J. Am. Chem. Soc. 1997; 119: 5833-5846.
48. Yu C, Yang TH, Yeh CJ, Chuang LC. Combined use of NMR, distance geometry, and restrained energy minimization for the conformational analysis of 8-lysine-vasopressin. Can. J. Chem. 1992; 70: 1950-1955.
49. 7)desamino-vasopressin analogues using NMR spectroscopy. J. Pept. Sci. 2002; 8: 347-364.
50. Langs DA, Smith GD, Stezowski JJ, Hughes RE. Structure of pressinoic acid: the cyclic moiety of vasopressin. Science 1986; 232: 1240-1242.
51. Wood SP, Tickle IJ, Treharne AM, Pitts JE, Mascarenhas Y, Li JY, Husain J, Cooper S, Blundell TL, Hruby VJ, Buku A, Fischman AJ, Wyssbrod HR. Crystal structure analysis of deamino-oxytocin: conformational flexibility receptor binding. Science 1986; 232: 633-636.
52. Husain J, Blundell TL, Cooper S, Pitts JE, Tickle IJ, Wood SP, Hruby VJ, Buku A, Fischman AJ, Wyssbrod HR, Mascarenhas Y. The conformation of deamino-oxytocin: X-ray analysis of the 'dry' and 'wet' form. Phil. Trans. R. Soc. Lond. B 1990; 327: 625-654.
53. Liwo A, Tempczyk A, Oldziej S, Shenderovich MD, Hruby VJ, Talluri S, Ciarkowski J, Kasprzykowski F, Łankiewicz L, Grzonka Z. Exploration of the conformational space of oxytocin and arginine-vasopressin using the electrostatically driven Monte Carlo and molecular dynamics methods. Biopolymers 1996; 38: 157-175.
54. Urry DW, Walter R. Proposed conformation of oxytocin in solution. Proc. Natl Acad. Sci. USA 1971: 68: 956-958.
55. Hruby VJ, Lebl M. In CRC Handbook of Neurohypophyseal Hormone Analogues Jost K, Lebl M, Brtnik F (eds). CRC Press: Boca Raton, FL, 1987; Vol. 1, 105-155.
56. Zieger G, Andreae F, Sterk H. Assignment of proton NMR resonance and conformational analysis of [Lys 8]-vasopressin homologues. Magn. Reson. Chem. 1991; 29: 580-586.
57. Meraldi JP, Hruby VJ, Brewster AIR. Relative conformational rigidity in oxytocin and [1-penicillaminel-oxytocin: a proposal for the relationship of conformational flexibility to hormone agonism and antagonism. Proc. Natl Acad. Sci. USA 1977; 74: 1373-1377.
58. Mosberg HI, Hruby VJ, Meraldi JP. Conformational study of the potent peptide hormone antagonist [1-penicillamine, 2-leucine]oxytocin in aqueous solution. Biochemistry 1981; 20: 2822-2828.
59. 1a receptor. Evidence for major localization within transmembrane regions. J. Biol. Chem. 1995; 270: 25771-25777.
60. Misicka A, Verheyden PMF, Van Binst G. Equilibrium of the cis/trans isomerization of the peptide bond with N-alkyl amino acids measured by 2D NMR. Lett. Pept. Sci. 1998; 5: 375-377.